The extent of medication reduction depends on your starting point, how well you respond to semaglutide, and your baseline diabetes severity
Clinical studies demonstrate that semaglutide achieves glycemic control with HbA1c reductions of 1.5% to 1.8% at antidiabetic doses (Ozempic 0.5-1.0 mg, Rybelsus 7-14 mg) and produces weight loss ranging from 5-10% in type 2 diabetes and 12-15% with higher doses (Wegovy 2.4 mg) in patients with obesity
(C) Contrasting Mechanistic Profiles of Resmetirom and Semaglutide
Despite their differences, both drugs work by augmenting a hormone that controls blood sugar and appetite
From which pharmacy
Lu H, Xie L, Guo L, Gu X, Zhu R, Yang Y, Tang F, Li M, Liu C, Wang D, Li M, Tian Y, Cai S